X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20076) 20076
Book Review (5579) 5579
Publication (1140) 1140
Magazine Article (149) 149
Book / eBook (66) 66
Conference Proceeding (53) 53
Book Chapter (35) 35
Dissertation (6) 6
Trade Publication Article (3) 3
Data Set (2) 2
Government Document (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18824) 18824
index medicus (18127) 18127
female (9839) 9839
male (9081) 9081
antidepressive agents - therapeutic use (8977) 8977
antidepressive agents - adverse effects (7344) 7344
psychiatry (7273) 7273
adult (6931) 6931
middle aged (5947) 5947
antidepressants (5275) 5275
pharmacology & pharmacy (4325) 4325
aged (4267) 4267
depressive disorder - drug therapy (4200) 4200
depression (4032) 4032
treatment outcome (3570) 3570
depression - drug therapy (2802) 2802
depressive disorder, major - drug therapy (2617) 2617
neurosciences (2538) 2538
clinical neurology (2455) 2455
adolescent (2439) 2439
double-blind (2324) 2324
animals (2288) 2288
antidepressive agents, second-generation - adverse effects (2200) 2200
antidepressive agents, tricyclic - adverse effects (2136) 2136
major depression (2127) 2127
abridged index medicus (2004) 2004
antidepressive agents, second-generation - therapeutic use (2001) 2001
antidepressive agents, tricyclic - therapeutic use (1964) 1964
serotonin uptake inhibitors - adverse effects (1956) 1956
risk factors (1947) 1947
serotonin uptake inhibitors - therapeutic use (1907) 1907
depression, mental (1882) 1882
antidepressive agents - administration & dosage (1855) 1855
double-blind method (1732) 1732
drug therapy (1714) 1714
antidepressive agents - pharmacology (1712) 1712
drug therapy, combination (1676) 1676
fluoxetine (1644) 1644
psychiatric status rating scales (1604) 1604
depressive disorder - psychology (1590) 1590
major depressive disorder (1544) 1544
dose-response relationship, drug (1489) 1489
medicine, general & internal (1407) 1407
serotonin reuptake inhibitors (1396) 1396
mental depression (1389) 1389
drug interactions (1334) 1334
antidepressant (1311) 1311
efficacy (1251) 1251
antipsychotic agents - therapeutic use (1210) 1210
child (1204) 1204
care and treatment (1171) 1171
antipsychotic agents - adverse effects (1129) 1129
analysis (1118) 1118
time factors (1098) 1098
bipolar disorder - drug therapy (1081) 1081
drugs (1066) 1066
aged, 80 and over (1065) 1065
young adult (1045) 1045
comorbidity (1034) 1034
risk (1024) 1024
research (1019) 1019
pregnancy (1010) 1010
serotonin (991) 991
randomized controlled trials as topic (986) 986
psychology, clinical (932) 932
placebo-controlled trial (928) 928
prevalence (925) 925
depressive disorder, major - psychology (903) 903
clinical trials as topic (887) 887
rats (873) 873
medicine & public health (849) 849
psychotherapy (849) 849
paroxetine (843) 843
placebo (826) 826
anxiety (819) 819
health aspects (813) 813
drug administration schedule (807) 807
depressive disorder - diagnosis (799) 799
metaanalysis (774) 774
venlafaxine hydrochloride (761) 761
follow-up studies (759) 759
bipolar disorder (757) 757
retrospective studies (754) 754
clinical trials (727) 727
internal medicine (727) 727
fluoxetine - therapeutic use (726) 726
sertraline (717) 717
depressive disorder, major - diagnosis (705) 705
antidepressants, tricyclic (698) 698
psychology (688) 688
severity of illness index (685) 685
combined modality therapy (683) 683
fluoxetine - adverse effects (676) 676
pharmacotherapy (676) 676
serotonin uptake inhibitors (671) 671
prospective studies (670) 670
disorder (669) 669
antidepressive agents, second-generation - administration & dosage (665) 665
article (654) 654
imipramine (651) 651
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (49) 49
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
UofT at Scarborough - Stacks (5) 5
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
UofT at Mississauga - Stacks (3) 3
Gerstein Science - Periodical Stacks (2) 2
UTL at Downsview - May be requested (2) 2
University College (Laidlaw) - Stacks (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Online Resources - Online (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Toronto East General Hospital - Chaplain Dept. (1) 1
UofT Schools - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18196) 18196
German (583) 583
French (552) 552
Spanish (156) 156
Japanese (127) 127
Russian (99) 99
Norwegian (91) 91
Danish (83) 83
Swedish (71) 71
Dutch (70) 70
Polish (65) 65
Italian (60) 60
Hungarian (39) 39
Portuguese (25) 25
Finnish (20) 20
Czech (17) 17
Chinese (15) 15
Turkish (11) 11
Romanian (6) 6
Hebrew (5) 5
Icelandic (3) 3
Lithuanian (2) 2
Slovak (2) 2
Bosnian (1) 1
Croatian (1) 1
Korean (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10047, pp. 881 - 890
Summary Background Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological... 
Internal Medicine | TRIALS | MEDICINE, GENERAL & INTERNAL | ACCEPTABILITY | MENTAL-HEALTH-CARE | TRENDS | GUIDELINES | Mianserin - adverse effects | Triazoles - administration & dosage | Triazoles - adverse effects | Humans | Citalopram - adverse effects | Sertraline - adverse effects | Venlafaxine Hydrochloride - adverse effects | Imipramine - administration & dosage | Paroxetine - adverse effects | Mianserin - analogs & derivatives | Paroxetine - administration & dosage | Desipramine - adverse effects | Nortriptyline - administration & dosage | Nortriptyline - adverse effects | Mianserin - administration & dosage | Child | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Clomipramine - administration & dosage | Duloxetine Hydrochloride - adverse effects | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Clomipramine - adverse effects | Evidence-Based Medicine | Desipramine - administration & dosage | Randomized Controlled Trials as Topic | Venlafaxine Hydrochloride - administration & dosage | Citalopram - administration & dosage | Confounding Factors (Epidemiology) | Sertraline - administration & dosage | Adolescent | Amitriptyline - adverse effects | Bayes Theorem | Fluoxetine - administration & dosage | Duloxetine Hydrochloride - administration & dosage | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Research Design | Amitriptyline - administration & dosage | Imipramine - adverse effects | Psychological aspects | Medical colleges | Neurosciences | Drugs and youth | Rankings | Comparative analysis | Child psychopathology | Major depressive disorder | Antidepressants, Tricyclic | Pediatric pharmacology | Mental illness | Studies | Teenagers | Mental depression | Antidepressants | Meta-analysis | Children & youth | Index Medicus | Abridged Index Medicus
Journal Article
JAMA Psychiatry, ISSN 2168-622X, 05/2015, Volume 72, Issue 5, pp. 438 - 445
IMPORTANCE: Antipsychotic medications are associated with increased mortality in older adults with dementia, yet their absolute effect on risk relative to no... 
MORTALITY | MEDICATIONS | METAANALYSIS | EFFICACY | PSYCHIATRY | ALZHEIMERS-DISEASE | NEUROPSYCHIATRIC SYMPTOMS | OLDER-ADULTS | DRUGS | PLACEBO-CONTROLLED TRIALS | ATYPICAL ANTIPSYCHOTICS | United States - epidemiology | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Risk | Case-Control Studies | Dose-Response Relationship, Drug | Psychotropic Drugs - adverse effects | Dibenzothiazepines - adverse effects | Risperidone - adverse effects | Female | Registries | Retrospective Studies | Dementia - drug therapy | Quetiapine Fumarate | Veterans - psychology | Psychotropic Drugs - administration & dosage | Haloperidol - adverse effects | Dementia - mortality | Antipsychotic Agents - administration & dosage | Aged | Benzodiazepines - adverse effects | Veterans - statistics & numerical data | Antidepressive Agents - adverse effects | Dosage and administration | Antipsychotic drugs | Mortality | Analysis | Risk factors | Dementia | Veterans | Comorbidity | Americans | Survivors | Outpatient Treatment | Longitudinal Study | Psychiatric Disorders | Epidemiology | Benzodiazepines | Conventional Antipsychotics | Anticonvulsants | Cognitive Disorders | Etiology | Psychopharmacology | Opioids | Aging | Antidepressant Drugs | Atypical Antipsychotics | PTSD (ICD-9) | Negative Therapeutic Reaction | Index Medicus | Abridged Index Medicus
Journal Article
BMJ, ISSN 0959-8138, 8/2011, Volume 343, Issue 7819, pp. 354 - 354
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 5, pp. 1078 - 1089
Background & Aims We performed a genome-wide association study (GWAS) to identify genetic risk factors for drug-induced liver injury (DILI) from licensed drugs... 
Gastroenterology and Hepatology | Side Effect | Medication | Liver Damage | Anti-Fungal Agent | POPULATION | SUSCEPTIBILITY | RISK | TERBINAFINE | TICLOPIDINE | HEPATITIS | CLASS-I | HEPATOTOXICITY | GASTROENTEROLOGY & HEPATOLOGY | T-CELLS | ANTIGEN | Antifungal Agents - adverse effects | Naphthalenes - adverse effects | Humans | Middle Aged | Male | Sertraline - adverse effects | Fenofibrate - adverse effects | Chromosomes, Human, Pair 2 - genetics | Ticlopidine - adverse effects | Female | Odds Ratio | Chemical and Drug Induced Liver Injury - etiology | Platelet Aggregation Inhibitors - adverse effects | Hypolipidemic Agents - adverse effects | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Genes, MHC Class I - genetics | Chemical and Drug Induced Liver Injury - genetics | Terbinafine | Phenotype | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Alleles | HLA-A Antigens - genetics | Polymorphism, Single Nucleotide | Antidepressive Agents - adverse effects | Drugs | Medical research | Liver diseases | Liver | Genes | Genomics | Risk factors | Genetic polymorphisms | Analysis | Gastrointestinal diseases | Medicine, Experimental | Genetic research | Trade and professional associations | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | side effect | medication | anti-fungal agent | liver damage | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Gastroenterologi | Klinisk medicin
Journal Article
Journal Article
Journal Article
Journal of Clinical Psychiatry, ISSN 0160-6689, 09/2010, Volume 71, Issue 9, pp. 1176 - 1186
Journal Article
Journal Article
Journal Article